Literature DB >> 33397973

Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling.

Yee Ming Khaw1,2, Danish Majid1,3, Sungjong Oh1,3, Eunjoo Kang1,2, Makoto Inoue4,5.   

Abstract

Environmental triggers have important functions in multiple sclerosis (MS) susceptibility, phenotype, and trajectory. Exposure to early life trauma (ELT) has been associated with higher relapse rates in MS patients; however, the underlying mechanisms are not well-defined. Here we show ELT induces mechanistic and phenotypical alterations during experimental autoimmune encephalitis (EAE). ELT sustains downregulation of immune cell adrenergic receptors, which can be attributed to chronic norepinephrine circulation. ELT-subjected mice exhibit interferon-β resistance and neurodegeneration driven by lymphotoxin and CXCR2 involvement. These phenotypic changes are observed in control EAE mice treated with β1 adrenergic receptor antagonist. Conversely, β1 adrenergic receptor agonist treatment to ELT mice abrogates phenotype changes via restoration of immune cell β1 adrenergic receptor function. Our results indicate that ELT alters EAE phenotype via downregulation of β1 adrenergic signaling in immune cells. These results have implications for the effect of environmental factors in provoking disease heterogeneity and might enable prediction of long-term outcomes in MS.

Entities:  

Year:  2021        PMID: 33397973     DOI: 10.1038/s41467-020-20302-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  79 in total

1.  A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis.

Authors:  P Ghadirian; B Dadgostar; R Azani; P Maisonneuve
Journal:  Can J Public Health       Date:  2001 Jul-Aug

Review 2.  Overview and diagnosis of multiple sclerosis.

Authors:  Samuel F Hunter
Journal:  Am J Manag Care       Date:  2016-06       Impact factor: 2.229

3.  Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada.

Authors:  P Ghadirian; M Jain; S Ducic; B Shatenstein; R Morisset
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

4.  Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Authors:  Sabine Cepok; Dun Zhou; Rajneesh Srivastava; Stefan Nessler; Susanne Stei; Konrad Büssow; Norbert Sommer; Bernhard Hemmer
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

Review 5.  Vitamin D and multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; K Claire Simon
Journal:  Lancet Neurol       Date:  2010-06       Impact factor: 44.182

Review 6.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

Authors:  H Lassmann; W Brück; C Lucchinetti
Journal:  Trends Mol Med       Date:  2001-03       Impact factor: 11.951

7.  Psychological stress as risk factor for exacerbations in multiple sclerosis.

Authors:  P Nisipeanu; A D Korczyn
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

8.  Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis.

Authors:  Francisco J Quintana; Mauricio F Farez; Vissia Viglietta; Antonio H Iglesias; Yifat Merbl; Guillermo Izquierdo; Miguel Lucas; Alexandre S Basso; Samia J Khoury; Claudia F Lucchinetti; Irun R Cohen; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

9.  Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.

Authors:  Anna K Hedström; Maria Bäärnhielm; Tomas Olsson; Lars Alfredsson
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

10.  Heterogeneity in multiple sclerosis: scratching the surface of a complex disease.

Authors:  Giulio Disanto; Antonio J Berlanga; Adam E Handel; Andrea E Para; Amy M Burrell; Anastasia Fries; Lahiru Handunnetthi; Gabriele C De Luca; Julia M Morahan
Journal:  Autoimmune Dis       Date:  2010-12-09
View more
  2 in total

Review 1.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

2.  Association of adverse childhood experiences with the development of multiple sclerosis.

Authors:  Karine Eid; Øivind Torkildsen; Jan Aarseth; Mari Aalstad; Alok Bhan; Elisabeth G Celius; Marianna Cortese; Anne Kjersti Daltveit; Trygve Holmøy; Kjell-Morten Myhr; Trond Riise; Stephan Schüler; Cecilie F Torkildsen; Stig Wergeland; Nils Erik Gilhus; Marte-Helene Bjørk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-04-04       Impact factor: 13.654

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.